TENAX THERAPEUTICS, INC. short interest in 2018
In 2018, TENAX THERAPEUTICS, INC.'s disclosed short interest ran from 3.56% of shares outstanding on 12 Jan 2018 to 2.36% on 31 Dec 2018, a change of -1.20 percentage points. The year's high was 11.56% on 13 Apr 2018 and its low 2.36% on 31 Dec 2018, averaging 7.22% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.84 days on 31 Aug 2018. Full history: TENAX THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 3.56% (12 Jan 2018)
- End of year
- 2.36% (31 Dec 2018)
- Change
- -1.20 pp
- High
- 11.56% (13 Apr 2018)
- Low
- 2.36% (31 Dec 2018)
- Average
- 7.22%
- Highest days to cover
- 18.84 (31 Aug 2018)
- SEC filings marked
- 4
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 3.56% | 3.84 | |
| 31 Jan 2018 | 4.45% | 2.63 | |
| 15 Feb 2018 | 5.08% | 4.55 | |
| 29 Mar 2018 | 10.44% | 2.68 | |
| 13 Apr 2018 | 11.56% | 1.00 | 10-K filed |
| 30 Apr 2018 | 11.09% | 3.00 | |
| 15 May 2018 | 10.25% | 2.67 | 10-Q filed |
| 31 May 2018 | 10.58% | 4.47 | |
| 15 Jun 2018 | 9.58% | 6.24 | |
| 29 Jun 2018 | 8.68% | 15.80 | |
| 13 Jul 2018 | 7.81% | 7.93 | |
| 31 Jul 2018 | 7.58% | 17.65 | |
| 15 Aug 2018 | 6.80% | 11.05 | 10-Q filed |
| 31 Aug 2018 | 6.60% | 18.84 | |
| 14 Sep 2018 | 6.34% | 11.87 | |
| 28 Sep 2018 | 6.07% | 11.98 | |
| 15 Oct 2018 | 5.74% | 13.87 | |
| 31 Oct 2018 | 5.03% | 7.98 | |
| 15 Nov 2018 | 4.83% | 4.66 | 10-Q filed |
| 31 Dec 2018 | 2.36% | 1.00 |
See also: TENAX THERAPEUTICS, INC.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.